Multifunctional rare earth oxide/MBG composite microspheres as a carrier for bone tumor treatment

Abstract

With the development of advanced composites, biomaterials have brought the field of tissue engineering and regeneration into a new era. Among them, composites of inorganic nonmetallic materials and rare earth oxides have unique structures and biochemical properties and have attracted widespread interest. In this work, rare earth oxides (CeO2)/inorganic nonmetallic materials (mesoporous bioactive glass, MBG) composite microspheres (CeO2/MBGs) were synthesized by a sol-gel method, and the in vitro biological effect of CeO2/MBGs was systematically studied. The filling of CeO2/MBGs in irregular bone tumor defects not only promoted osteogenic mineralization in MG63 cells but also had significant antibacterial effects on E. coli and S. aureus. CeO2 enters the MBG network as a network modifier, while doxorubicin (DOX) is adsorbed into the mesoporous structure through electrostatic interactions, which endows CeO2/MBGs with excellent bioactivity and controlled DOX release behavior. Moreover, the results of in vitro experiments showed that the proper addition of rare earth oxides had no toxic effect on normal cells, and the combination of rare earth oxides with antitumor drugs could slow the release of DOX through the use of an intelligent response design system, thus inducing the apoptosis of MG63 cells. This work suggested that combination chemotherapy and the design of a rare earth oxide/MBG composite microspheres may be potential therapeutic approaches for the postoperative repair of bone tumor defects. The construction of this multifunctional rare earth oxide/inorganic biocomposite provides a way to apply the material to bone tissue.